MedTrace Logo

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

NCT06958315 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-04-16

No results posted yet for this study

Summary

This study aims to address several key questions regarding the use of inclisiran in real-world clinical practice in Spain.

Conditions

  • Atherosclerotic Vascular Disease
  • Heterozygous Familial Hypercholesterolemia

Interventions

OTHER

Inclisiran

This is an observational study, there is no treatment allocation.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-16
Primary Completion
2027-05-01
Completion
2027-05-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06958315 on ClinicalTrials.gov